A massive warehouse of paper products was totally destroyed by fire. A video on social media shows fires inside a warehouse, ...

Kimberly-Clark (KMB), near 52-week lows, offers a 5.2% yield, Q1 organic growth, and Kenvue merger synergies—see why it’s a ...

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the cheap NASDAQ stocks to buy right now. On April 28, Kimberly-Clark reported solid Q1 2026 results, delivering $4.2 billion in net sales, a 2.7% ...

Kimberly-Clark (NasdaqGS:KMB) announced an agreement to acquire Kenvue, expanding its reach in consumer health brands. The company is realigning its joint venture with Suzano, which includes plans to ...

Global companies are adopting AI at their Indian centers to streamline ad creation, reducing reliance on agencies and cutting ...

Kimberly-Clark will buy Kenvue for $48.7 billion. A merged Kimberly-Clark-Kenvue could have $32 billion in annual sales and profits as high as $5.5 billion. At Kimberly-Clark's current $40 billion ...

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q1 2026 investor letter for its “Large Cap ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Kenvue shareholders will receive $3.50 per share in ...

(Reuters) -Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, ...

CHICAGO -- Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own ...